NCT02394951View on ClinicalTrials.gov

Pregabalin in CIPN

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 2, 2018

Study Completion Date

April 2, 2018

Conditions
NeuropathyPain
Interventions
DRUG

Pregabalin

Anticonvulsant

DRUG

Placebo

Identical, matching inactive substance

Trial Locations (1)

63110

Washington University School of Medicine/Barnes Jewish Hospital, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT02394951 - Pregabalin in CIPN | Biotech Hunter | Biotech Hunter